Physician profile
Karima Addetia
NPI 1740612993
$37,132.02
in general payments reported to CMS, 2019-2025
15 companies · $1,231 in 2025
The $1,231 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $9,294 · 2021: $305 · 2022: $299 · 2023: $295 · 2024: $148 · 2025: $1,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $915 · Food and Beverage: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $915.20 |
| Food and Beverage | $758.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $34,261.51 | 2019-2023 | |
| Edwards Lifesciences Corporation | $1,113.45 | 2025 | Evoque |
| Astrazeneca Pharmaceuticals LP | $427.63 | 2020-2025 | Brilinta, Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $382.49 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $203.13 | 2020-2022 | |
| Lantheus Medical Imaging, INC. | $169.34 | 2019-2023 | Definity |
| Abbott Laboratories | $127.18 | 2023-2025 | Amplatzer, Amplatzer Amulet |
| Pfizer INC. | $122.71 | 2020-2023 | |
| Heartflow, INC. | $115.73 | 2020-2025 | |
| Amgen INC. | $72.64 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $42.71 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $30.97 | 2023-2025 | Camzyos |
| Boston Scientific Corporation | $29.75 | 2024 | Watchman Flx |
| Medtronic, INC. | $17.42 | 2024 | Corevalve Evolut R |
| Merck Sharp & Dohme LLC | $15.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karima Addetia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.